Published in Hepatitis Weekly, December 12th, 2005
Data from the Combination of Efavirenz and Truvada (COMET) study at the 10th European AIDS Conference (EACS) in Dublin, Ireland was presented by study investigator Peter Ruane, MD of Lifesource Medical Inc....
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.